「japan」の検索結果
85件：66～70件目を表示
-
研发产品管线 | 研究与开发 | 千寿制药株式会社
） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeApplication under review（Japan） SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlusion (CRAO)P3（Japan） SJP-0170Gla...
http://www.senju.co.jp/chinese/rd/pipeline.html -
研发产品管线 | 研究与开发 | 千寿制药株式会社
） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeApplication under review（Japan） SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlusion (CRAO)P3（Japan） SJP-0170Gla...
https://www.senju.co.jp/chinese/rd/pipeline.html -
y 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co.,...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
y 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co.,...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distributi...
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101_0.pdf